TriSalus Life Sciences (TLSI) Current Leases (2022 - 2026)
TriSalus Life Sciences' (TLSI) quarterly Current Leases came in at $218000.0 in Q1 2026, up 84.75% year-on-year from $118000.0 in Q1 2025, and up 30.54% quarter-over-quarter from $167000.0 in Q4 2025.
TriSalus Life Sciences (TLSI) Current Leases (2022 - 2026) Analysis & Trends
TriSalus Life Sciences' Current Leases history runs 5 years deep, the most recent figure standing at $218000.0 for Q1 2026.
- On a quarterly basis, Current Leases rose 84.75% year-over-year to $218000.0 in Q1 2026; TTM through Mar 2026 was $218000.0, a 84.75% increase from a year earlier, with the FY2025 full-year figure at $167000.0, down 22.69% from the prior year.
- Current Leases rose to $218000.0 in Q1 2026 per TLSI's latest filing, from $167000.0 in the prior quarter.
- Across five years, Current Leases topped out at $379000.0 in Q3 2023 and bottomed at $118000.0 in Q1 2025.
- The 5-year median for Current Leases is $242000.0 (2024), against an average of $251916.7.
- Across the five-year window, Current Leases sank 67.49% in 2025 and surged 84.75% in 2026, its largest moves.
- Year by year, Current Leases stood at $370000.0 in 2022, then dropped by 5.14% to $351000.0 in 2023, then sank by 38.46% to $216000.0 in 2024, then slipped by 22.69% to $167000.0 in 2025, then soared by 30.54% to $218000.0 in 2026.
- Per Business Quant, the three latest TLSI Current Leases figures stand at $218000.0 (Q1 2026), $167000.0 (Q4 2025), and $129000.0 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | 24.30 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | 20.50 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | - |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | TriSalus Life Sciences | 220.07 Mn | 163.52 Mn | 7.67 Mn | 218,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 218,000.00 |
| Dec 31, 2025 | 167,000.00 |
| Sep 30, 2025 | 129,000.00 |
| Jun 30, 2025 | 123,000.00 |
| Mar 31, 2025 | 118,000.00 |
| Dec 31, 2024 | 216,000.00 |
| Sep 30, 2024 | 266,000.00 |
| Jun 30, 2024 | 323,000.00 |
| Mar 31, 2024 | 363,000.00 |
| Dec 31, 2023 | 351,000.00 |
| Sep 30, 2023 | 379,000.00 |
| Dec 31, 2022 | 370,000.00 |